equilab about us

About Us

Equilab International was established in November 2002. Through incessant research and innovation, this company is dedicated to be an independent provider of Bioavailability/Bioequivalence (BA/BE) studies. Answering our clients’ needs, in June 2006 Equilab International launched a new unit within PT Equilab International organizational structure, called as Clinical Research Unit (CRU) that focus in Clinical Study implementation as a Contract Research Organization.

Our BA/BE Unit is the first BA/BE laboratory in Indonesia that has been accredited with ISO/IEC 17025:2000 by The National Accreditation Body of Indonesia (KAN) in August 2004 as a general requirement for Testing and Calibration Laboratory competency. This unit has developed more than 100 validated and accredited bioanalytical method (per February 2012) and this number will increase from time by time as we develop and validate new bioanalytical method. Our professional teams offer the innovative technologies, science, expertise, accurate and rapid assay results.

Our Clinical Research Unit (CRU) provide a comprehensive and high quality clinical research with wide range of services including project setup, site and investigator selection, protocol and clinical study documents development, project management and clinical monitoring, data management, bio-statistical analysis, final report development, and post-study services. Supported by our expert and Good Clinical Practice (GCP) certified staff, we perform good management clinical research comply to GCP and deliver your clinical trial to be efficient in cost and time with integrity and validity of clinical trial data and reliable study result.

In 2011, we launched comparative dissolution testing service to support successful BE study result by evaluating the drugs similarity compare to the reference drug in in-vitro condition. To assist our clients in meeting the equivalence requirement, our professional staffs are willing to discuss the study result and give advice for your product development.

Located in Jakarta, Indonesia, our office has an integrated clinical and analytical site. Our quality system, resources, and facilities are managed to meet the regulatory authority requirements and international standard for GCP, GLP, and BA/BE study to ensure our study report acceptance in local Drug Regulatory Authority. We are also aware about recent international regulation issues and guidelines in order to provide the best services.

With never ending achievement and continuously improvement in our quality system and services, we commit to bring client’s trust into client’s satisfaction in a long term relationship. We are high commitment to quality, integrity, and confidentiality to be your reliable partner in BA/BE studies and clinical trials.